University of California, Irvine researchers have identified a gene expressed during regeneration that is critical for muscle repair. The key human skeletal muscle gene was also found in a subset of muscle fibers that were able to support human muscle stem cells after transplantation.
Although skeletal muscle is one of the most regenerative organ systems, there exists a need to improve regeneration for the more than 400 chronic muscle disorders and injuries that present clinically, including rotator cuff injuries and certain muscle disorders like Duchenne Muscular Dystrophy (DMD) or congenital muscular dystrophy.
Michael H. Hicks, PhD, assistant professor in the Department of Physiology & Biophysics at UCI School of Medicine, is the co-corresponding author of the study, along with April D. Pyle, PhD, professor in the Department of Microbiology, Immunology and Molecular Genetics at UCLA.
The study Regenerating human skeletal muscle forms an emerging niche in vivo to support PAX7 cells, was published in November in Nature Cell Biology.
When confronted with an injury, our muscles naturally do a good job at repairing themselves. However, in severe injuries and genetic muscular diseases the muscle is unable to meet the demands of regenerating new tissues. Researchers say one solution is to take the cells from a dish and replicate how a healthy human body repairs muscle as newly generated muscle made in a lab can support stem cells better than the exhausted muscle tissue.
One disorder the Hicks lab hopes to treat with their lab-grown muscle progenitors is tears to the rotator cuff muscles, which affects up to 30% of people over the age of 65.
Damage to the rotator cuff muscles and tendon result in loss of mobility, prolonged hospitalization, and increased dependency on health care providers. Even after surgical attachment of the rotator cuff tendon to the bone, the muscle often fails to regenerate or incompletely regenerates, leading to decreased function.
Hicks was also recently funded by the UCI Anti-Cancer Challenge to use his approach for muscle reconstruction after radiation therapy for cancer survivors.
Muscle stem cells are supported within anatomically defined specialized compartments, termed niches, that regulate their balance of self-renewal and differentiation over a person’s lifetime. The ability to establish new stem cells niches is essential for long-term cell therapies, in which transplanted muscle stem cells must balance the formation of new muscle fibers and maintain the stem cell pool to respond to future injuries.
Researchers demonstrated the formation of regenerating human myofibers following transplantation are a key source of niche emergence from transplanted human cells, which has previously been overlooked.
The researchers further characterized the interaction of transplanted muscle progenitor cells with the subset of muscle fibers a unique gene called ACTC1 using a new technology called spatial RNA sequencing. The equipment recently obtained by the UCI Genomics Research and Technology Hub, has a powerful ability to perform segmentation of cell types directly adjacent to one another and to obtain RNA information from those cell types.
In the future, the team plans to dive deeper into restored muscle function including assessing the ability of the newly formed human muscles to connect with the motor neurons to restore motor control to the transplanted cells.
The Hicks lab at the UCI School of Medicine is pursuing both basic and translational avenues as their next steps. The ability to generate these muscle stem cells in the lab is currently under patent review by the US, Europe, and Japan. Hicks and Pyle also have plans to start a company to translate muscle stem cells for patients.
In a previous study from 2017, Hicks and Pyle made strides to create and repair skeletal muscle, termed progenitor cells, in the lab with gene editing. Yet to date, retention of human muscle progenitors after transplantation from cells grown in the lab has proven challenging.
Results from this study have identified several key receptors and ligand candidates on the muscle progenitor cells that could allow for them to interact with the myofibers, but these candidates will need to be validated before they can be used as therapeutic targets to improve muscle regeneration.
The study was funded by the Muscular Dystrophy Association, the NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NAIMS), the UCI Institute for Clinical and Translational Science, and the California Institute for Regenerative Medicine.
Each year, the UCI School of Medicine educates more than 400 medical students and nearly 150 PhD and MS students. More than 700 residents and fellows are trained at the UCI Medical Center and affiliated institutions. Multiple MD, PhD and MS degrees are offered. Students are encouraged to pursue an expansive range of interests and options. For medical students, there are numerous concurrent dual degree programs, including an MD/MBA, MD/MPH, or an MD/MS degree through one of three mission-based programs: the Health Education to Advance Leaders in Integrative Medicine (HEAL-IM), the Program in Medical Education for Leadership Education to Advance Diversity-African, Black and Caribbean (PRIME LEAD-ABC), and the Program in Medical Education for the Latino Community (PRIME-LC). The UCI School of Medicine is accredited by the Liaison Committee on Medical Accreditation and ranks among the top 50 nationwide for research. For more information, visit medschool.uci.edu.(VP/Newswise)
